SCHEMBL8558905

SCHEMBL8558905

COc1ccc(CC2NCCc3cc(OC)c(OC)c(O)c32)cc1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TBXA2R P21731 3/20 0.59
KDM4E B2RXH2 2/20 0.57
MAPT P10636 2/20 0.57
PKM P14618 2/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
BCHE P06276 1/20 0.57
ADRB2 P07550 2/20 0.55
ADRB1 P08588 2/20 0.55
ADRB3 P13945 2/20 0.55
HTR1A P08908 1/20 0.54
ADRA2A P08913 1/20 0.54
DRD1 P21728 1/20 0.54
PTGS1 P23219 1/20 0.54
OPRM1 P35372 1/20 0.54
DRD3 P35462 1/20 0.54
DHFR P00374 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9126409 0.90 TBXA2R (0.64) TBXA2RKDM4EMAPTPKMBCHE
SCHEMBL8982846 0.90 TBXA2R (0.63) TBXA2RBCHEADRB2ADRB1ADRB3
SCHEMBL8982767 0.90 TBXA2R (0.63) TBXA2RKDM4EMAPTPKMBCHE
SCHEMBL27617352 0.90 KDM4E (0.54) TBXA2RKDM4EMAPTPKMMEN1
SCHEMBL8983089 0.89 TBXA2R (0.57) TBXA2RBCHEADRB2ADRB1ADRB3
SCHEMBL8982764 0.89 TBXA2R (0.49) TBXA2RKDM4EMAPTPKMMEN1
SCHEMBL8982937 0.88 TBXA2R (0.73) TBXA2RBCHEADRB2ADRB1ADRB3
SCHEMBL8982903 0.87 TBXA2R (0.52) TBXA2RKDM4EMAPTPKMMEN1
SCHEMBL8982838 0.86 BCHE (0.49) TBXA2RKDM4EMAPTPKMMEN1
SCHEMBL8982857 0.82 TBXA2R (0.54) TBXA2RKDM4EMAPTPKMBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0617022-B1 6,7, dialkoxy-3,4-dihydroisoquinolin-8-ol, process for preparation thereof and process for preparation of 6,7-dialkoxy-1,2,3,4-tetrahydroisoquinolin-8-ol using the compound BANYU PHARMA CO LTD (JP) 1998-02-11 EP disclosed
EP-0501693-B1 Isoquinoline derivatives BANYU PHARMA CO LTD (JP) 1996-08-28 EP disclosed
US-5498717-A CHEMICAL INTERMEDIATES FOR PRODUCING ANTITUMOR POTENTIATORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-03-12 US disclosed
US-5446164-A Regioselective cyclization of phenethylamide derivative in presence of phosphoric acid halide, reducing formed compound BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-29 US disclosed
US-5362736-A Alkoxy derivatives for cardiovascular disorders BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-11-08 US disclosed
EP-0501693-A1 Isoquinoline derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1992-09-02 EP disclosed